Overview

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The goals of this study are: A. To determine whether olanzapine can help patients with bipolar disorder who currently have mild to moderate mania. B. To assess the safety of olanzapine and any side effects that might be associated with it, as well as the quality of life and functioning of patients treated with olanzapine. C. To assess how olanzapine compares to divalproex.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Olanzapine
Valproic Acid